Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre.
CONCLUSION: The seroprevalence of B. burgdorferi among our patients with uveitis was 7.9% compared with6%â€"8.5% in the general French population which leads to a low predictive value of serological testing. Its use should be reserved for patients with unexplained uveitis, an exposure history, systemic findings suggestive of Lyme disease and steroids resistance.
PMID: 28659389 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Bernard A, Kodjikian L, Abukhashabh A, Roure-Sobas C, Boibieux A, Denis P, Broussolle C, Seve P Tags: Br J Ophthalmol Source Type: research
More News: Borrelia | France Health | Laboratory Medicine | Lyme Disease | Opthalmology | Study | UK Health | Women